For instance, semaglutide has been approved and is being researched for indications including obesity, T2DM, reducing cardiovascular risk, chronic kidney disease, NAFLD, and AD, indicating that the development of new indications could provide new growth opportunities for GLP-1 drugs
Both of these effects slow down the rate at which food is digested and make you feel fuller
Notably, participants in the 12mg group had not reached a weight loss plateau at 48 weeks, suggesting that longer treatment durations could yield even greater reductions
Consume prunes and prune juice
So if youve handled GLP-1 side effects well in the past, your healthcare provider may have you leapfrog ahead to the 5 mg dose
Contact Aesthetics and Medical Lasers of Colorado for a personalized consultation today